Friedenthal Financial Takes Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Friedenthal Financial purchased a new position in Omega Healthcare Investors, Inc. (NYSE:OHI) in the third quarter, Holdings Channel.com reports. The fund purchased 18,697 shares of the real estate investment trust’s stock, valued at approximately $761,000.

Other large investors have also added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in shares of Omega Healthcare Investors by 353.4% in the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 516 shares during the period. Versant Capital Management Inc purchased a new position in shares of Omega Healthcare Investors during the second quarter valued at about $26,000. DiNuzzo Private Wealth Inc. bought a new position in Omega Healthcare Investors in the third quarter worth about $33,000. V Square Quantitative Management LLC lifted its holdings in Omega Healthcare Investors by 49.5% in the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock worth $40,000 after buying an additional 323 shares during the period. Finally, WFA Asset Management Corp bought a new stake in Omega Healthcare Investors during the 1st quarter valued at approximately $39,000. Institutional investors own 65.25% of the company’s stock.

Insider Activity

In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Truist Financial upped their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. BMO Capital Markets lifted their price target on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and raised their target price for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Finally, Berenberg Bank initiated coverage on Omega Healthcare Investors in a research report on Friday. They issued a “buy” rating and a $45.00 price target on the stock. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $37.80.

Omega Healthcare Investors Stock Performance

OHI stock opened at $41.61 on Friday. The stock’s 50 day simple moving average is $39.71 and its 200 day simple moving average is $35.23. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $41.62. The stock has a market capitalization of $10.73 billion, a PE ratio of 31.76, a price-to-earnings-growth ratio of 1.29 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The business had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. During the same quarter in the prior year, the firm earned $0.74 EPS. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. As a group, research analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.44%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s payout ratio is presently 204.58%.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.